Treatment of relapsed acute myeloid leukaemia after allogeneic bone marrow transplantation with combination chemotherapy of cytarabine, idarubicin plus etoposide and subsequent donor leukocyte infusion: a prospective study

被引：0
|
作者：
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, JH [1 ]
Kim, S [1 ]
Seol, M [1 ]
Lee, YS [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [11] Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
    Au, WY
    Lie, AKW
    Lee, CK
    Liang, R
    Kwong, YL
    BONE MARROW TRANSPLANTATION, 1999, 23 (11) : 1201 - 1203
  • [12] Allogeneic bone marrow transplantation for relapsed acute myeloid leukaemia (AML) - Reply
    Atkinson, K
    Downs, K
    Concannon, A
    Milliken, S
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (04): : 571 - 571
  • [13] Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
    WY Au
    AKW Lie
    CK Lee
    R Liang
    YL Kwong
    Bone Marrow Transplantation, 1999, 23 : 1201 - 1203
  • [14] Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse
    S-J Choi
    J-H Lee
    J-H Lee
    S Kim
    M Seol
    Y-S Lee
    J-S Lee
    W-K Kim
    H-S Chi
    K-H Lee
    Leukemia, 2004, 18 : 1789 - 1797
  • [15] Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse
    Choi, SJ
    Lee, JH
    Lee, JH
    Kim, S
    Seol, M
    Lee, YS
    Lee, JS
    Kim, WK
    Chi, HS
    Lee, KH
    LEUKEMIA, 2004, 18 (11) : 1789 - 1797
  • [16] Prospective trial of chemotherapy plus donor leukocyte infusions (DLI) to treat relapsed advanced myeloid leukemia after related bone marrow transplantation (BMT).
    Levine, JE
    Penza, S
    Topolsky, D
    Beatty, P
    Rifkin, R
    Giralt, S
    Porter, DL
    Drobyski, WR
    Horowitz, MM
    Collins, RH
    BLOOD, 1999, 94 (10) : 668A - 668A
  • [17] A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
    Fiedler, Walter
    Chromik, Joerg
    Amberg, Stefanie
    Kebenko, Maxim
    Thol, Felicitas
    Schlipfenbacher, Vera
    Christine Wilke, Anne
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Ganser, Arnold
    Bokemeyer, Carsten
    Theile, Susann
    Deppermann, Ute
    Kranich, Anne L.
    Heuser, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : E169 - E173
  • [18] DONOR LEUKOCYTE INFUSIONS FOR CHRONIC MYELOID-LEUKEMIA RELAPSED AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BAR, BMAM
    SCHATTENBERG, A
    MENSINK, EJBM
    VANKESSEL, AG
    SMETSERS, TFCM
    KNOPS, GHJN
    LINDERS, EHP
    DEWITTE, T
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 513 - 519
  • [19] SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
    Advani, Anjali S.
    McDonough, Shannon
    Copelan, Edward
    Willman, Cheryl
    Mulford, Deborah A.
    List, Alan F.
    Sekeres, Mikkael A.
    Othus, Megan
    Appelbaum, Frederick R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 233 - 237
  • [20] Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia
    Gopcsa, L
    Barta, A
    Banyai, A
    Konya, M
    Pajor, L
    Földi, J
    Paloczi, K
    BONE MARROW TRANSPLANTATION, 2002, 29 (05) : 449 - 452
12345